499 related articles for article (PubMed ID: 28027934)
1. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
[TBL] [Abstract][Full Text] [Related]
2. Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non‑alcoholic fatty liver disease.
Cai C; Yu H; Huang G; Du X; Yu X; Zhou Y; Shen W
Int J Mol Med; 2018 Sep; 42(3):1215-1228. PubMed ID: 29786745
[TBL] [Abstract][Full Text] [Related]
3. Dietary supplementation with myo-inositol reduces high-fructose diet-induced hepatic ChREBP binding and acetylation of histones H3 and H4 on the Elovl6 gene in rats.
Hibi M; Nakagawa T; Hayakawa T; Yanase E; Shimada M
Nutr Res; 2021 Apr; 88():28-33. PubMed ID: 33743322
[TBL] [Abstract][Full Text] [Related]
4. ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model.
Suzuki T; Muramatsu T; Morioka K; Goda T; Mochizuki K
Nutrition; 2015 Jun; 31(6):877-83. PubMed ID: 25933497
[TBL] [Abstract][Full Text] [Related]
5. Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet.
Shimada M; Ichigo Y; Shirouchi B; Takashima S; Inagaki M; Nakagawa T; Hayakawa T
Nutr Res; 2019 Apr; 64():49-55. PubMed ID: 30802722
[TBL] [Abstract][Full Text] [Related]
6. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes.
Dubuquoy C; Robichon C; Lasnier F; Langlois C; Dugail I; Foufelle F; Girard J; Burnol AF; Postic C; Moldes M
J Hepatol; 2011 Jul; 55(1):145-53. PubMed ID: 21145868
[TBL] [Abstract][Full Text] [Related]
7. Bindings of ChREBP and SREBP1, and histone acetylation around the rat liver fatty acid synthase gene are associated with induction of the gene during the suckling-weaning transition.
Morishita S; Mochizuki K; Goda T
J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):94-100. PubMed ID: 24975218
[TBL] [Abstract][Full Text] [Related]
8. Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c.
Teran-Garcia M; Adamson AW; Yu G; Rufo C; Suchankova G; Dreesen TD; Tekle M; Clarke SD; Gettys TW
Biochem J; 2007 Mar; 402(3):591-600. PubMed ID: 17313375
[TBL] [Abstract][Full Text] [Related]
9. Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor.
Hansmannel F; Mordier S; Iynedjian PB
Biochem J; 2006 Oct; 399(2):275-83. PubMed ID: 16834571
[TBL] [Abstract][Full Text] [Related]
10. Mono-2-ethylhexyl phthalate induces the expression of genes involved in fatty acid synthesis in HepG2 cells.
Bai J; He Z; Li Y; Jiang X; Yu H; Tan Q
Environ Toxicol Pharmacol; 2019 Jul; 69():104-111. PubMed ID: 31004931
[TBL] [Abstract][Full Text] [Related]
11. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats.
Ma LL; Yuan YY; Zhao M; Zhou XR; Jehangir T; Wang FY; Xi Y; Bu SZ
Chin J Nat Med; 2018 Jun; 16(6):411-417. PubMed ID: 30047462
[TBL] [Abstract][Full Text] [Related]
12. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
13. F6P/G6P-mediated ChREBP activation promotes the insulin resistance-driven hepatic lipid deposition in zebrafish.
Gong Y; Lu Q; Xi L; Liu Y; Yang B; Su J; Liu H; Jin J; Zhang Z; Yang Y; Zhu X; Xie S; Han D
J Nutr Biochem; 2023 Dec; 122():109452. PubMed ID: 37748621
[TBL] [Abstract][Full Text] [Related]
14. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.
Dentin R; Pégorier JP; Benhamed F; Foufelle F; Ferré P; Fauveau V; Magnuson MA; Girard J; Postic C
J Biol Chem; 2004 May; 279(19):20314-26. PubMed ID: 14985368
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid synthase promoter: characterization, and transcriptional regulation by sterol regulatory element binding protein-1 in goat mammary epithelial cells.
Li J; Luo J; Xu H; Wang M; Zhu J; Shi H; Haile AB; Wang H; Sun Y
Gene; 2015 Apr; 561(1):157-64. PubMed ID: 25688876
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
18. The SRE Motif in the Human PNPLA3 Promoter (-97 to -88 bp) Mediates Transactivational Effects of SREBP-1c.
Liang H; Xu J; Xu F; Liu H; Yuan D; Yuan S; Cai M; Yan J; Weng J
J Cell Physiol; 2015 Sep; 230(9):2224-32. PubMed ID: 25655569
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Elovl6 gene expression is regulated by the synergistic action of ChREBP and SREBP-1c.
Bae JS; Oh AR; Lee HJ; Ahn YH; Cha JY
Biochem Biophys Res Commun; 2016 Sep; 478(3):1060-6. PubMed ID: 27524233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
